PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Conference

09 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results

24 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira to Report 2021 Financial Results on Thursday February 24, 2022

16 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37.3 Million for January 2022

15 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7 Million

06 Jan 2022 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

03 Jan 2022 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B

09 Dec 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021

07 Dec 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

23 Nov 2021 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management

19 Nov 2021 08:40:10 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the Jefferies London Healthcare Conference

10 Nov 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021

09 Nov 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira Files Lawsuit Against eVenus for Patent Infringement

08 Nov 2021 16:30:14 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2021 Financial Results

03 Nov 2021 08:00:03 By Nasdaq GlobeNewswire

Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition

02 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021

27 Oct 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management

11 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Host Investor Day on October 15th, 2021 in Tampa, FL

08 Oct 2021 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Notified of Abbreviated New Drug Application Filing for EXPAREL®

04 Oct 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon Facility

30 Sep 2021 07:30:00 By Nasdaq GlobeNewswire